![Chadwick J. Orevillo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Chadwick J. Orevillo
Director de Operaciones en LONGBOARD PHARMACEUTICALS, INC. .
Perfil
Chadwick J.
Orevillo is currently the Vice President & Head-Operations at Longboard Pharmaceuticals, Inc. He previously worked as the Director-Clinical Development at Novartis Corp., Principal at Merck & Co., Inc. and Kendle International LLC, Vice President & Head-Clinical Operations at Arena Pharmaceuticals, Inc., Vice President & Head-Clinical Operations at Pearl Therapeutics, Inc., and Principal at Pharmacia, Inc. and Pharmaco LSR, Inc. Orevillo holds a graduate degree from Tulane University (Louisiana) and an undergraduate degree from William Paterson University.
Cargos activos de Chadwick J. Orevillo
Empresas | Cargo | Inicio |
---|---|---|
LONGBOARD PHARMACEUTICALS, INC. | Director de Operaciones | - |
Antiguos cargos conocidos de Chadwick J. Orevillo.
Empresas | Cargo | Fin |
---|---|---|
ARENA PHARMACEUTICALS | Corporate Officer/Principal | 01/03/2020 |
Novartis Corp.
![]() Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/2008 |
Pharmacia, Inc. | Corporate Officer/Principal | 01/01/2003 |
MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2000 |
Pharmaco LSR, Inc.
![]() Pharmaco LSR, Inc. Miscellaneous Commercial ServicesCommercial Services Pharmaco LSR, Inc. provides clinical research services. | Corporate Officer/Principal | 01/01/1995 |
Formación de Chadwick J. Orevillo.
William Paterson University | Undergraduate Degree |
Tulane University (Louisiana) | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
MERCK & CO., INC. | Health Technology |
LONGBOARD PHARMACEUTICALS, INC. | Health Technology |
Empresas privadas | 6 |
---|---|
Pearl Therapeutics, Inc.
![]() Pearl Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pearl Therapeutics, Inc. develops therapies for the treatment of chronic respiratory diseases. It offers respiratory product development, high quality therapies for COPD, Asthma and treatment and prevention of chronic respiratory diseases and asthma. The company was founded in 2006 by Sarvajna Dwivedi and is headquartered in Redwood City, CA. | Health Technology |
Novartis Corp.
![]() Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
Pharmacia, Inc. | |
Kendle International LLC
![]() Kendle International LLC Miscellaneous Commercial ServicesCommercial Services Kendle International LLC provides research and development services to biopharmaceutical companies by offering value-added clinical research services and proprietary information technology. The company was founded in 1981 and is headquartered in Cincinnati, OH. | Commercial Services |
Pharmaco LSR, Inc.
![]() Pharmaco LSR, Inc. Miscellaneous Commercial ServicesCommercial Services Pharmaco LSR, Inc. provides clinical research services. | Commercial Services |
Arena Pharmaceuticals, Inc.
![]() Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
- Bolsa de valores
- Insiders
- Chadwick J. Orevillo